Skip to main content
. 2022 Oct 17;15:147. doi: 10.1186/s13045-022-01360-x

Fig. 3.

Fig. 3

Potential mechanisms of PARP inhibitor resistance. In a clinical setting, the mechanisms of resistance to PARP inhibitors (PARPi) present heterogeneity and mainly consist of a restoration of homologous recombination (HR) ability; b protection of replication fork stability; c reduction in PARP1 trapping; d mutations in cell cycle components; e efflux of the PGP-mediated drug pump; f interference in the microRNA (miRNA) environment